What is BDRX's relative strength rating?

BDRX ranks at the 5th percentile over 1 month, 4th percentile over 3 months, 3th percentile over 6 months, 2th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is BDRX in?

BDRX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is BDRX in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). BDRX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is BDRX?

BDRX currently shows a 20-day average daily range (ADR%) of 15.5%, a 90-day beta versus the S&P 500 of 0.91. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does BDRX have a seasonal pattern?

TickerStance computes BDRX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what BDRX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did BDRX last report earnings?

No SEC EDGAR filings are linked to BDRX in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) has a 3-month relative strength percentile of 4 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 24. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 15.5%, relative volume 0.26×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month4pctile

6 month3pctile

1 year2pctile

Classic3IBD pctile

LDR5leadership

0 of 5 lenses lit · avg RS pctile 3

✓ADR%15.5%!A/DE!RVOL0.26×!$ Vol$481K

COMPUTED · AS OF 2026-08-24

Pattern read

BDRX is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -42.4% / -85.1%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

5

3m

4

6m

3

1y

2

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · BDRX

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
BDRX
4RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

ASBPAspire Biopharma Holdings, Inc. Common Stock3 CNTXContext Therapeutics Inc. Common Stock3 RNAAtrium Therapeutics, Inc. Common Stock3 RGCRegencell Bioscience Holdings Limited Ordinary Shares3

§ Seasonality

10y · since 2023

Best monthAug on averageavg +-1.04% · 33% win · n 3

Worst monthDec on averageavg -34.60% · 0% win · n 3

BDRX monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	BDRX Jan avg: -17.72% median: -22.03% win: 33% σ: 24.64% n: 3 2023-03-28 → 2026-07-31	BDRX Feb avg: -28.18% median: -24.42% win: 0% σ: 9.50% n: 3 2023-03-28 → 2026-07-31	BDRX Mar avg: -23.17% median: -29.93% win: 25% σ: 38.20% n: 4 2023-03-28 → 2026-07-31	BDRX Apr avg: -9.14% median: -2.58% win: 50% σ: 23.03% n: 4 2023-03-28 → 2026-07-31	BDRX May avg: -28.63% median: -31.08% win: 25% σ: 30.37% n: 4 2023-03-28 → 2026-07-31	BDRX Jun avg: -15.37% median: -17.24% win: 0% σ: 5.72% n: 4 2023-03-28 → 2026-07-31	BDRX Jul avg: -21.89% median: -16.12% win: 0% σ: 23.68% n: 4 2023-03-28 → 2026-07-31	BDRX Aug avg: -1.04% median: -20.29% win: 33% σ: 41.51% n: 3 2023-03-28 → 2026-07-31 (current)	BDRX Sep avg: -22.07% median: -37.55% win: 33% σ: 36.89% n: 3 2023-03-28 → 2026-07-31	BDRX Oct avg: -13.96% median: -12.83% win: 0% σ: 9.77% n: 3 2023-03-28 → 2026-07-31	BDRX Nov avg: -13.76% median: -8.62% win: 0% σ: 12.90% n: 3 2023-03-28 → 2026-07-31	BDRX Dec avg: -34.60% median: -27.94% win: 0% σ: 13.28% n: 3 2023-03-28 → 2026-07-31

Public attention · BDRX

Is the crowd watching?

39/ 100 · vs its own 90-day norm▲ 10 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out1.0Mshares

Market cap$1.2MNano Cap

FAQ

Frequently asked questions

What is BDRX's relative strength rating?: BDRX ranks at the 5th percentile over 1 month, 4th percentile over 3 months, 3th percentile over 6 months, 2th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is BDRX in?: BDRX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is BDRX in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). BDRX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is BDRX?: BDRX currently shows a 20-day average daily range (ADR%) of 15.5%, a 90-day beta versus the S&P 500 of 0.91. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does BDRX have a seasonal pattern?: TickerStance computes BDRX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what BDRX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) — Stance & relative strength

BDRX is not confirmed as a leader. 4 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?